Top

Published in:

01-10-2015 | Original Article

Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection

Authors: Zhixin Yang, Yu Lei, Chunbo Chen, Hong Ren, Tongdong Shi

Published in: Archives of Virology | Issue 10/2015

Abstract

One of the main responses of invariant natural killer T (iNKT) cells to antigen stimulation is the rapid production of interleukin (IL)-4 and interferon (IFN)-γ cytokines. There is a decline in the function of iNKT cells in chronic hepatitis B (CHB) patients. In this study, we explored the impact of programmed cell death 1 (PD-1), T cell immunoglobulin mucin-3 (Tim-3), and cluster of differentiation 28 (CD28) expression on iNKT cell functions in CHB patients. Flow cytometry was used to test iNKT frequencies and levels of PD-1, Tim-3, CD28, IL-4, and IFN-γ secreted by iNKT cells. An enzyme-linked immunosorbent assay (ELISA) was used to measure IL-4 and IFN-γ secretion upon α-galactosylceramide (α-GalCer) activation ex vivo. We found that the levels of expression of PD-1 and Tim-3 from iNKT cells in CHB patients were significantly higher than in healthy donors (p < 0.05), but there was lower expression of CD28 (p < 0.05) and an impaired capability to produce IL-4 and IFN-γ (p < 0.05). In vitro α-GalCer stimulation upregulated the expression of PD-1⁺ iNKT cells (p < 0.05), Tim-3⁺ iNKT cells (p < 0.05), and CD28⁺ iNKT cells (p < 0.05). In response to combination therapies consisting of α-GalCer and anti-PDL1 monoclonal antibody (mAb) and/or anti-Tim-3 mAbs and/or anti-CD80/anti-CD28 mAbs, IL-4⁺ and IFN-γ⁺ iNKT cells demonstrated different degrees of growth (p < 0.05). The functional decline of iNKT cells was closely related to the decrease in CD28 expression and the increases of Tim-3 and PD-1. In addition, clinical antiviral treatment with lamivudine could partially restore the immune function of iNKT cells in CHB patients.

Lai CL, Ratziu V, Yuen MF, Poynard T (2003) Viral hepatitisB. Lancet 362:2089–2094CrossRefPubMed

Jung MC, Pape GR (2002) Immunology of hepatitis B infection. Lancet Infect Dis 2:43–50CrossRefPubMed

Tang TJ, Kwekkeboom J, Mancham S, Binda RS, de Man RA, Schalm SW et al (2005) Intrahepatic CD8 T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. J Hepatol 43:45–52CrossRefPubMed

Boin C, Penna A, Bertoletti A, LamonacaV Rapti I, Missale G et al (2003) Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 39:595–605CrossRef

Venkataswamy MM, Porcelli SA (2010) Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 22:68–78PubMedCentralCrossRefPubMed

Matsuda JL, Mallevaey T, Scott-Brown J, Gapin L (2008) CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr Opin Immunol 20:358–368PubMedCentralCrossRefPubMed

Taniguchi M, Harada M, Kojo S et al (2003) The regulatory role of Valpha 14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21:483–513CrossRefPubMed

Gumperz JE, Miyake S, Yamamura T et al (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625–636PubMedCentralCrossRefPubMed

Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2:557–568PubMed

10.

Schurich A, Pallett LJ, Lubowiecki M, Singh HD, Gill US et al (2013) The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. J PLoS Pathog 9(3):e1003208CrossRef

11.

Bayard F, Godon O, Nalpas B, Costentin C, Zhu R, Soussan P et al (2012) T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO. J Viral Hepat 12:872–880CrossRef

12.

Grimm D, Heeg M, Thimme R (2013) Hepatitis B virus: from immunobiology to immunotherapy. J Clin Sci Lond 124(2):77–85CrossRef

13.

Ito H, Ando K, Ishikawa T et al (2008) Role of Valpha14 + NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14 + NKT cells promotes the breakage of CTL tolerance. Int Immunol 20(7):869–879CrossRefPubMed

14.

Kakimi K, Guidotti LG, Koezuka Y, Chisari FV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192(7):921–930PubMedCentralCrossRefPubMed

15.

Boni C, Fisiearo P, Valdatta C et al (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Viro1 81:4215–4225CrossRef

16.

Trautmann L, Janbazian L, Chomont N et al (2006) Upregulation of PD-1 expression on HIV-specific CD8⁺ T cells leads to reversible immune dysfunction. Nat Med 12(10):1198–1202CrossRefPubMed

17.

Ha SJ, Mueller SN, Wherry EJ, Freeman GJ, Ahmed R et al (2008) Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 205(3):543–555PubMedCentralCrossRefPubMed

18.

Ju Y, Hou N, Zhang XN et al (2009) Blockade of Tim-3 pathway ameliorates interferon-γ production from hepatic CD8⁺ T cells in a mouse model of hepatitis B virus infection. Cell Mol Immunol 6(1):35–43PubMedCentralCrossRefPubMed

19.

Golden-Mason L, Palmer BE, Kassam N, Rosen HR et al (2009) Negative immune regulator Tim-3 is over expressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4⁺ and CD8⁺ T cells. J Virol 83(18):9122–9130PubMedCentralCrossRefPubMed

20.

Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536–541CrossRefPubMed

21.

Nebbia G, Peppa D, Schurich A, Khanna P, Sing HD et al (2012) Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 7(10):e47648. doi:10.1371/journal.pone.0047648 PubMedCentralCrossRefPubMed

22.

Oikawa T, Kamimura Y, Akiba H et al (2006) Preferential involvement of Tim-3 in the regulation of hepatic CD8⁺ T cells in murine acute graft-versus-host disease. J Immunol 177:4281–4287CrossRefPubMed

23.

Day CL, Kaufmann DE, Kiepiela P, Brown JA et al (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350–354CrossRefPubMed

24.

Barber DL, Wherry EJ, Masopust D et al (2006) Restoring function in exhausted CD8⁺ T cells during chronic viral infection. Nature 439:682–687CrossRefPubMed

25.

Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ et al (2013) Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS ONE 8(3):e59302. doi:10.1371/journal.pone.0059302 PubMedCentralCrossRefPubMed

26.

Zhang E, Zhang X, Liu J, Wang B, Tian Y et al (2011) The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection. PLoS ONE 6(10):e26196. doi:10.1371/journal.pone.0026196 PubMedCentralCrossRefPubMed

27.

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C (2007) Characterization of hepatitis B virus(HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81:4215–4225PubMedCentralCrossRefPubMed

28.

Fujii S, Shimizu K, Smith C et al (2003) Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198(2):267–279PubMedCentralCrossRefPubMed

29.

Sabatos CA, Chakravarti S, Cha E et al (2003) Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4:1102–1110CrossRefPubMed

30.

Jones RB, Ndhlovu LC, Barbour JD et al (2008) Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205:2763–2779PubMedCentralCrossRefPubMed

31.

McClary H, Koch R, Chisari FV, Guidotti LG (2000) Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74(5):2255–2264PubMedCentralCrossRefPubMed

Title: Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection
Authors: Zhixin Yang
Yu Lei
Chunbo Chen
Hong Ren
Tongdong Shi
Publication date: 01-10-2015
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 10/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-015-2539-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2015

Effect of amino acid sequence variations at position 149 on the fusogenic activity of the subtype B avian metapneumovirus fusion protein

New porcine epidemic diarrhoea virus variant with a large deletion in the spike gene identified in domestic pigs

Variation analysis of E1 and E2 in HCV subtypes

Response from Yu Xiang to “Comment on The complete nucleotide sequence and genome organization of pea streak virus (genus Carlavirus)”

Full genome analysis of bovine astrovirus from fecal samples of cattle in Japan: identification of possible interspecies transmission of bovine astrovirus

Human norovirus genogroup II recombinants in Thailand, 2009–2014

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials